Evidence map›Paper›PMID 32686188›Full record

ArticleAmerican journal of primatology2020

The human-primate interface in the New Normal: Challenges and opportunities for primatologists in the COVID-19 era and beyond.

Susan Lappan, Suchinda Malaivijitnond, Sindhu Radhakrishna, Erin P Riley, Nadine Ruppert

Open access · bronzeAbstract read
In one paragraph

Article in American journal of primatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Is biomedical research demand driving a monkey business?One health (Amsterdam, Netherlands) · 2023
    Article
  9. Article
  10. Impact of the COVID-19 Pandemic on Primate Research and Conservation.Animals : an open access journal from MDPI · 2022
    Article
  11. Advocacy and Activism as Essential Tools in Primate Conservation.International journal of primatology · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Susan LappanDepartment of Anthropology, Appalachian State University, Boone, North Carolina.ORCID 0000-0002-0139-8837
Suchinda MalaivijitnondNational Primate Research Center of Thailand, Chulalongkorn University, Kaeng Khoi, Saraburi, Thailand.ORCID 0000-0003-0897-2632
Sindhu RadhakrishnaNational Institute of Advanced Studies, Indian Institute of Science, Bengaluru, India.ORCID 0000-0002-0870-071X
Erin P RileyDepartment of Anthropology, San Diego State University, San Diego, California.ORCID 0000-0002-2679-0595
Nadine RuppertSchool of Biological Sciences, Universiti Sains Malaysia, Penang, Malaysia.ORCID 0000-0002-9760-0058
Universiti Sains Malaysia · MYChulalongkorn University · THNational Institute of Advanced Studies · INSan Diego State University · US

Funding

American Institute for Indonesian StudiesAppalachian State UniversityDepartment of Science and Technology, Government of India SERB/F/I0032/2016-17Disney Conservation Fund awarded through Malaysian Primatological SocietyHasanuddin UniversityMinistry of Higher Education Malaysia FRGS/PBIOLOGI/6711649San Diego State UniversityThailand Research Fund Senior Scholar Grant RTA 6280010The Habitat FoundationThe Rufford FoundationUniversiti Sains Malaysia RU/PBIOLOGI/8011063USA Fulbright Scholar ProgramWenner Gren Foundation
6 · The paper itself

Abstract

The emergence of SARS-CoV-2 in late 2019 and human responses to the resulting COVID-19 pandemic in early 2020 have rapidly changed many aspects of human behavior, including our interactions with wildlife. In this commentary, we identify challenges and opportunities at human-primate interfaces in light of COVID-19, focusing on examples from Asia, and make recommendations for researchers working with wild primates to reduce zoonosis risk and leverage research opportunities. First, we briefly review the evidence for zoonotic origins of SARS-CoV-2 and discuss risks of zoonosis at the human-primate interface. We then identify challenges that the pandemic has caused for primates, including reduced nutrition, increased intraspecific competition, and increased poaching risk, as well as challenges facing primatologists, including lost research opportunities. Subsequently, we highlight opportunities arising from pandemic-related lockdowns and public health messaging, including opportunities to reduce the intensity of problematic human-primate interfaces, opportunities to reduce the risk of zoonosis between humans and primates, opportunities to reduce legal and illegal trade in primates, new opportunities for research on human-primate interfaces, and opportunities for community education. Finally, we recommend specific actions that primatologists should take to reduce contact and aggression between humans and primates, to reduce demand for primates as pets, to reduce risks of zoonosis in the context of field research, and to improve understanding of human-primate interfaces. Reducing the risk of zoonosis and promoting the well-being of humans and primates at our interfaces will require substantial changes from "business as usual." We encourage primatologists to help lead the way.

Indexed as

AnimalsConservation of Natural ResourcesCoronavirus InfectionsCOVID-19Feeding BehaviorHumansPandemicsPneumonia, ViralPrimate DiseasesPrimatesRisk FactorsZoonosesbiosafetyethicshuman-primate conflictprovisioningSARS-CoV-2zoonosis

Identifiers

PMID32686188
PMCPMC7404331
OpenAlexW3042383900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.